Orthopediatrics Revenue Growth Rates (KIDS), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Orthopediatrics Corp  (NASDAQ: KIDS)
 

KIDS's Revenue Growth by Quarter and Year

Orthopediatrics's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/KIDS/growth
https://api.csimarket.com/api/v1/companies/KIDS/fundamentals
https://api.csimarket.com/api/v1/companies/KIDS/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
KIDS Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 72.66
2nd Quarter June 70.51
1st Quarter March 58.39
FY 201.56

KIDSs Annual Revenue
Orthopediatrics's Revenue in the fiscal year 2025 $ 235.66 millions
Orthopediatrics's Revenue in the fiscal year 2024 $ 204.60 millions
Orthopediatrics's Revenue in the fiscal year 2023 $ 148.25 millions
Orthopediatrics's Revenue in the fiscal year 2022 $ 122.29 millions
Orthopediatrics's Revenue in the fiscal year 2021 $ 98.05 millions




KIDS Revenue third quarter 2026 Y/Y Growth Comment
Orthopediatrics Corp reported Revenue improvement of 20.56% year on year in the third quarter 2026, to $ 72.66 millions, this is lower than Orthopediatrics Corp's recent average Revenue improvement of 23.38%.

Looking into third quarter 2026 results within Medical Equipment & Supplies industry 70 other companies have achieved higher Revenue growth. While Orthopediatrics Corp' s Revenue rise of 20.56% ranks overall at the positon no. 1268 in the third quarter 2026.


KIDS Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 20.56 %
2nd Quarter June 15.55 %
1st Quarter March 11.73 %
FY   -

Financial Statements
Orthopediatrics's third quarter 2026 Revenue $ 72.66 millions KIDS's Income Statement
Orthopediatrics's third quarter 2025 Revenue $ 60.27 millions Quarterly KIDS's Income Statement


KIDS Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 3.05 %
2nd Quarter June 20.76 %
1st Quarter March -5.99 %
FY (Year on Year)   -


Back to KIDS Growth rate Comparisons >> Back to KIDS Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #71
Healthcare Sector #227
Overall #1268

Revenue Y/Y Growth Statistics
High Average Low
96.39 % 23.38 % -25.31 %
(Dec 31 2024)   (Dec 31 2020)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #71
Healthcare Sector #227
Overall #1268
Revenue Y/Y Growth Statistics
High Average Low
96.39 % 23.38 % -25.31 %
(Dec 31 2024)   (Dec 31 2020)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Orthopediatrics's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
63.36 % 6.52 % -16.89 %
(Sep 30 2020)  


KIDS's III. Quarter Q/Q Revenue Comment
Orthopediatrics Corp achieved in the III. Quarter 2026 below company average Revenue growth of 3.05% quarter on quarter, to $ 72.66 millions.

Although the III. Quarter 2026 Revenue Q/Q growth was lower than the regular , this has been yet encouraging story, as the III. Quarter surge, eclipses the -1.23% growth in the III. Quarter a year ago

Within Medical Equipment & Supplies industry 23 other companies have achieved higher Revenue quarter on quarter growth. While Orthopediatrics's Revenue growth quarter on quarter, overall rank is 503.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #24
Healthcare Sector #99
Overall #503
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #24
Healthcare Sector #99
Overall #503
Revenue Q/Q Growth Statistics
High Average Low
63.36 % 6.52 % -16.89 %
(Sep 30 2020)  


KIDS's III. Quarter Q/Q Revenue Comment
Orthopediatrics Corp achieved in the III. Quarter 2026 below company average Revenue growth of 3.05% quarter on quarter, to $ 72.66 millions.

III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -1.23% in the III. Quarter a year ago.

Within Medical Equipment & Supplies industry 23 other companies have achieved higher Revenue quarter on quarter growth. While Orthopediatrics's Revenue growth quarter on quarter, overall rank is 503.


Orthopediatrics's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)		 12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 263.66
Y / Y Revenue Growth (TTM) 16.09 %
Year on Year Revenue Growth Overall Ranking # 636
Seqeuential Revenue Change (TTM) 4.93 %
Seq. Revenue Growth (TTM) Overall Ranking # 2206


Cumulative Revenue growth Comment
Although Orthopediatrics's Annual Revenue growth year on year were below company's average 22.95% , Revenue announced in the Sep 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 16.09% year on year, from 13.75% in Jun 30 2026.

In the Healthcare sector 133 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 64 to 636.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 120
Healthcare Sector # 134
Overall # 636

Revenue TTM Y/Y Growth Statistics
High Average Low
38.01 %
 22.95 %
-2.03 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 120
Sector # 325
S&P 500 # 2206
Cumulative Revenue growth Comment
Although Orthopediatrics's Annual Revenue growth year on year were below company's average 22.95% , Revenue announced in the Sep 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 16.09% year on year, from 13.75% in Jun 30 2026.

In the Healthcare sector 133 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 64 to 636.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 120
Healthcare Sector # 134
Overall # 636

Revenue TTM Y/Y Growth Statistics
High Average Low
38.01 %
22.95 %
-2.03 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 120
Sector # 325
S&P 500 # 2206




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
KIDS's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Natera Inc 34.08%$ 34.077 millions
Establishment Labs Holdings Inc 34.08%$ 34.075 millions
Beone Medicines Ltd 33.86%$ 33.861 millions
Ceribell Inc 33.72%$ 33.721 millions
Zomedica Corp 33.12%$ 33.123 millions
Intuitive Surgical Inc 32.71%$ 32.714 millions
Adc Therapeutics Sa32.20%$ 32.197 millions
Biomarin Pharmaceutical Inc32.02%$ 32.019 millions
The Pennant Group Inc 31.96%$ 31.965 millions
Beta Bionics Inc 30.92%$ 30.923 millions
Cadre Holdings inc 30.36%$ 30.362 millions
Krystal Biotech Inc 30.21%$ 30.206 millions
Sight Sciences Inc 29.83%$ 29.828 millions
Ge Healthcare Technologies Inc 29.41%$ 29.413 millions
Moderna Inc 29.23%$ 29.232 millions
Sonoma Pharmaceuticals Inc 28.02%$ 28.016 millions
Ani Pharmaceuticals Inc27.64%$ 27.638 millions
Geron Corporation27.45%$ 27.448 millions
Vericel Corporation26.47%$ 26.470 millions
Axogen inc 26.22%$ 26.218 millions
Cardio Diagnostics Holdings Inc 25.74%$ 25.744 millions
Edap Tms Sa25.55%$ 25.549 millions
Lifestance Health Group Inc 25.30%$ 25.303 millions
Rockwell Medical inc 25.21%$ 25.210 millions
Intelligent Bio Solutions Inc 25.19%$ 25.188 millions
The Oncology Institute Inc 24.31%$ 24.313 millions
Vanda Pharmaceuticals Inc 24.10%$ 24.098 millions
Mannkind Corporation24.04%$ 24.035 millions
Castle Biosciences Inc 23.90%$ 23.901 millions
Coherus Oncology inc 23.36%$ 23.360 millions


About Orthopediatrics Revenue Growth Rates (KIDS), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Orthopediatrics Corp (CIK 1425450).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001425450-26-000094
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Orthopediatrics Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.